Carnitor

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

AsthmaRheumatoid ArthritisHeart FailureMultiple SclerosisChronic Kidney DiseaseAcute Lymphoblastic LeukemiaHIV InfectionAnemiaSeptic ShockSpinal Cord InjuryPeripheral NeuropathyPolycystic Ovary SyndromeHypotensionEncephalopathyInfertilityNon-Alcoholic Fatty Liver DiseaseGastrointestinal Stromal TumorCytomegalovirus InfectionAIDSPyelonephritisGlucose IntoleranceMuscle WeaknessAzoospermiaHyperthyroidismProximal Spinal Muscular AtrophyPostpoliomyelitis SyndromeVentricular Septal DefectSpinal Muscular Atrophy, Type 1Familial Atrioventricular Septal Defect

1050 competitors in Asthma

#DrugCompanyPhaseTrials

1

Carnitor

LLeadiant Biosciences, Inc.

Approved

182

Singulair

AstraZeneca

Preclinical

173

Nucala

GGlaxo Dba Glaxosmithkline

Preclinical

354

Cinqair

Teva

Preclinical

135

Dupixent

AAzienda U.S.L. 1 di Massa e Carrara

Preclinical

306

Spiriva

Boehringer Ingelheim

Preclinical

87

Qvar

Chiesi Farmaceutici S.p.A.

Preclinical

88

Atrovent

Boehringer Ingelheim

Preclinical

59

Arcoxia

Novartis

Preclinical

—10

Formoterol Fumarate

AstraZeneca

Preclinical

8Show 20 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Effectiveness5 trials

The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs

Completed·Gilead·Phase 2·NCT00002379·100 enrolled

The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00001087·300 enrolled

Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations

Completed·Gilead·N/A·NCT00002398

Show 2 more trials

The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 3·NCT00001082·505 enrolled

Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children

Unknown status·Gilead·Phase 2·NCT00002219·36 enrolled

Drug2 trials

A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·N/A·NCT00000892·300 enrolled

A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00000912·475 enrolled

Heart Failure2 trials

Oral Carnitine in Heart Failure Patients

Not yet recruiting·LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's·Phase 1·NCT07201714·20 enrolled

The Clinical Study of the Efficacy and Safety of L-Carnitine Injection in Treatment of Heart Failure

Completed·LLee's Pharmaceutical Limited·Phase 2/3·NCT01580553·268 enrolled

Fatigue1 trial

Effect of Levocarnitine Supplementation for the Management of Fatigue in Levothyroxine-Treated Hypothyroid Patients

Unknown status·—·N/A·NCT03372772·90 enrolled

Safety and Efficacy1 trial

A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient

Completed·Gilead·Phase 2·NCT00002184·120 enrolled

7 more indications

Peripheral Neuropathy1 trial

A Randomized Controlled Trial to Assess the Effect of L-carnitine in Patients With Diabetic Peripheral Neuropathy to Relief Pain and Symptom Improvement

Unknown status·—·Phase 2·NCT04145245·104 enrolled

Sjogren's Syndrome1 trial

Levocarnitine for Dry Eye in Sjogren's Syndrome

Completed·VVanderbilt University Medical Center·Phase 2·NCT03953703·15 enrolled

Acute Lymphoblastic Leukemia1 trial

Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia

Recruiting·—·Phase 1·NCT05501899·20 enrolled

Treatment1 trial

Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00000885·440 enrolled

Dialysis Patients1 trial

Effects of L-carnitine Therapy on the Heart of Maintenance Hemodialysis Patients

Completed·TThe First Affiliated Hospital of Zhejiang Chinese Medical University·Phase 4·NCT05673239·1,008 enrolled

Anemia1 trial

Levocarnitine for Reducing ESA Requirements in Hemodialysis Patients With Renal Anemia

Not yet recruiting·—·Phase 4·NCT07160452·94 enrolled

HIV1 trial

Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir

Completed·Merck & Co.·Phase 3·NCT00002220·120 enrolled

Regulatory

FDA Approval Timeline[4]

Details

Drug Info

Related News